Parnika Antibiotics Private Limited

Parnika Antibiotics Private Limited - financial services in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1988PTC048379 Incorporated 05 August 1988 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company financial services
Revenue · FY 2025
₹34.78 Lakh
▲ 49% YoY
Net profit · FY 2025
₹23.1 Lakh
Net margin 66.4%
EBITDA · FY 2025
₹34.54 Lakh
EBITDA margin 99.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
38 yrs
Est. 1988
Directors on board
3
As per MCA filings
Last financials
Mar 2024
Balance sheet date

About Parnika Antibiotics Private Limited

Data last updated:

Parnika Antibiotics Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the brokerage and trading services segment of the financial services sector. It was incorporated on 05 August 1988 and has been in existence for over 38 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1988PTC048379.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sunita Ashokkumar Damani and Rajkumar Damani.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹34.78 Lakh, a growth of 49% compared to the previous year. For the same year it recorded a net profit of ₹23.1 Lakh (net margin 66.4%) and EBITDA of ₹34.54 Lakh (EBITDA margin 99.3%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 5% over five years.

Court records list 1 case involving the company, including 1 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24230MH1988PTC048379
Registration Number 048379
Incorporation Date 05 August 1988
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Parnika Antibiotics Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    10 Floor G Plot 10 Bandukwala Building British Hotel Lane Bombay Stock Exchang, E Fort, Mumbai, Maharashtra, India – 400001
  • Industry
    Financial Services, Brokerage & Trading Services

To see the full contact details of Parnika Antibiotics Private Limited, buy the company report.

Comprehensive company report
Parnika Antibiotics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Parnika Antibiotics Private Limited

FY 2024 filings available

Parnika Antibiotics Private Limited reported revenue of ₹34.78 Lakh (up 49% YoY) for FY 2025.

Revenue · FY 2025
₹34.78 Lakh ▲ 49%
Net profit · FY 2025
₹23.1 Lakh margin 66.4%
EBITDA · FY 2025
₹34.54 Lakh margin 99.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 49%
3 years · compounded
▲ 12%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 13%
5 years · compounded
▲ 5%

Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 49% growth in the latest year. EBITDA rose 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹34.54 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹23.1 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin99.3%
Net Profit Margin66.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Parnika Antibiotics Private Limited, buy the company report.

Board of directors of Parnika Antibiotics Private Limited

Parnika Antibiotics has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sunita Ashokkumar DamaniDirector02 Jun 20215 Years 5 MonthsCurrent
Rajkumar DamaniDirector05 Aug 198838 Years 3 MonthsCurrent
Ashok Kumar Kishori Lal DamaniDirector05 Aug 198838 Years 3 MonthsCurrent

Peer comparison

Parnika Antibiotics Private Limited is compared with the 8 companies closest to it by revenue in the BFSI industry (Broking Services), with the same principal business activity (other financial activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sar Organizers Private Limited₹34.93 Lakh (FY 2025)-17.0%Ahmedabad, Gujarat, India
Prudent Broking Services Private Limited₹34.9 Lakh (FY 2023)-34.0%Ahmedabad, Gujarat, India
Adilakshmi Finvest Private Limited₹34.79 Lakh (FY 2025)11.0%Delhi, India
Parnika Antibiotics Private Limitedthis company₹34.78 Lakh (FY 2025)₹23.1 Lakh66.4%49.0%Mumbai, Maharashtra, India
Cardinal Broking Services Private Limited₹34.73 Lakh (FY 2025)44.0%Mumbai, Maharashtra, India
Phoenix Share and Stockbrokers Private Limited₹34.72 Lakh (FY 2025)24.0%Mumbai, Maharashtra, India
India Technology Investments Private Limited₹34.7 Lakh (FY 2024)42.0%Mumbai, Maharashtra, India
Value Rock Broking Services Private Limited₹34.68 Lakh (FY 2025)-92.0%Mumbai, Maharashtra, India
Raman Commodities Private Limited₹34.61 Lakh (FY 2025)681.0%Bathinda, Punjab, India

To see the full peer comparison of Parnika Antibiotics Private Limited, buy the company report.

Auditor

Parnika Antibiotics Private Limited is audited by G.DAGA & CO for the financial year 2022.

Auditor firmFinancial yearFirm registration number
G.DAGA & COFY 2022101990W

Shareholding

The shareholding of Parnika Antibiotics Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Parnika Antibiotics Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Parnika Antibiotics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Parnika Antibiotics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Parnika Antibiotics Private Limited has 5 board changes on record since 1988: 3 appointments and 2 cessations. The latest: Sunita Ashokkumar Damani ceased to be Additional Director on 30 Sep 2022.

AGM
Parnika Antibiotics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Parnika Antibiotics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Sunita Ashokkumar Damani ceased to be Additional Director.
Appointed
Sunita Ashokkumar Damani was appointed as Director.
Ceased
Suman Rajkumar Damani ceased to be Additional Director.
Appointed
Ashok Kumar Kishori Lal Damani was appointed as Director.
Appointed
Rajkumar Damani was appointed as Director.
Incorporation
05 Aug 1988
Parnika Antibiotics Private Limited was registered on 05 Aug 1988 with Roc Mumbai & aged 38 years 3 months as per MCA records.

Frequently asked questions

Parnika Antibiotics is an active private limited company based in Mumbai, Maharashtra, India. The company works in brokerage and trading services, within the financial services industry. It was incorporated on 05 August 1988 (38+ years old) and is registered under CIN U24230MH1988PTC048379.

Parnika Antibiotics has 3 current directors:

The latest financial statements of Parnika Antibiotics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Parnika Antibiotics is U24230MH1988PTC048379. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Parnika Antibiotics has 1 court case on record: 1 filed against it.

Parnika Antibiotics was incorporated on 05 August 1988, making it 38+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Parnika Antibiotics by revenue are Sar Organizers Private Limited, Prudent Broking Services Private Limited, Adilakshmi Finvest Private Limited, Cardinal Broking Services Private Limited, Phoenix Share and Stockbrokers Private Limited and 3 more, all in the BFSI industry (Broking Services), with the same principal business activity (other financial activities).

Sunita Ashokkumar Damani ceased to be Additional Director on 30 Sep 2022. Sunita Ashokkumar Damani was appointed as Director on 02 Jun 2021. Suman Rajkumar Damani ceased to be Additional Director on 29 Sep 2017. Parnika Antibiotics has 5 board changes on record in total.

The registered office of Parnika Antibiotics is at 10 Floor G Plot 10 Bandukwala Building British Hotel Lane Bombay Stock Exchang, E Fort, Mumbai, Maharashtra, India – 400001.

Parnika Antibiotics operates in the financial services industry, in the brokerage and trading services segment.

The compliance status of Parnika Antibiotics is compliant as of 17 September 2026. The company is actively filing with the Registrar of Companies.